Patents by Inventor Alan SANDERCOCK

Alan SANDERCOCK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR INHIBITING CANCER STEM CELLS
    Publication number: 20220195037
    Abstract: The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express LOX1.
    Type: Application
    Filed: December 2, 2021
    Publication date: June 23, 2022
    Inventors: Elaine M. HURT, Ralph MINTER, Steven RUST, Alan SANDERCOCK, Sotirios KARATHANASIS
  • Compositions and methods for inhibiting cancer stem cells
    Patent number: 11192948
    Abstract: The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express LOX1.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: December 7, 2021
    Assignee: MedImmune Limited
    Inventors: Elaine M. Hurt, Ralph Minter, Steven Rust, Alan Sandercock, Sotirios Karathanasis
  • COMPOSITIONS AND METHODS FOR INHIBITING CANCER STEM CELLS
    Publication number: 20180273616
    Abstract: The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express LOX1.
    Type: Application
    Filed: September 29, 2016
    Publication date: September 27, 2018
    Inventors: Elaine M. HURT, Ralph MINTER, Steven RUST, Alan SANDERCOCK, Sotirios KARATHANASIS